Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD) were presented during the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions, held May 18-20 in Phoenix, AZ. Results found marijuana users are at a significantly increased risk of developing PAD, compared to the general population.
May 19, 2023
Marijuana Users Three Times More Likely to Develop Peripheral Artery Disease
May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (…
Read More
Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves
May 19, 2023
New Late-breaking Data Reinforce the Benefits of Abbott's TriClip Device for People with Tricuspid Valve Disease
May 19, 2023 — Abbott announced late-breaking data that add to the body of clinical evidence supporting the benefits of…
Read More
The platform is designed to expand the information available to clinicians prescribing the Epi+Gen CHD and PrecisionCHD laboratory developed tests (LDTs)
May 19, 2023
Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management
May 19, 2023 — Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine…
Read More
Figure 1. Results from the PROTECT II RCT, PROTECT III and RESTORE-EF Pooled Data Analysis
May 19, 2023
Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI
May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing…
Read More
Assert-IQ\ ICM is the world’s longest lasting Bluetooth - enabled insertable cardiac monitor
May 18, 2023
Abbott Receives FDA Clearance for Assert-IQ Insertable Cardiac Monitor 
May 18, 2023 — Abbott announced its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug…
Read More
The first of Vektor Medical's new studies, being presented at HRS 2023, showcases vMap’s utility in unstable ventricular tachycardia (VT) ablation. (Graphic: Business Wire)
May 18, 2023
Vektor Medical Releases Compelling Results for vMap Utility
May 18, 2023 — Vektor Medical, pioneers of technology to accurately map arrhythmias using only 12-lead ECG data,…
Read More
54-year-old patient with COVID-19 who underwent full angiographic reperfusion (extended thrombolysis in cerebral ischemia score = 3) after acute ischemic stroke. Top: Automated readout summary of CT perfusion data at presentation shows large mismatch volume (54 mL). Bottom: Follow-up MR image shows progression in infarction growth, with final infarction volume of approximately 72 cm3 (600% increase from CT perfusion imaging estimate of 9 mL shown in A). 
May 18, 2023
Infarction Growth, Penumbral Consumption After Reperfusion in COVID Vaccine-NaĂŻve Patients
May 18, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), SARS…
Read More
Jasmina Brooks
May 17, 2023
Jasmina Brooks Named President of Biosense Webster
May 17, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmiatreatment and part of Johnson & Johnson…
Read More
R-One+ is a robotic solution that allows the interventional cardiologist to perform coronary angioplasties by controlling the devices using an integrated control command unit located in the cathlab or in the control room
May 17, 2023
Robocath Launches New Robotic Platform R-One+
May 17, 2023 — Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment…
Read More
Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.
May 17, 2023
Data from Benchmark Registry Demonstrate Improved TAVR Efficiency with Preserved Patient Safety
May 17, 2023 — Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the…
Read More
Late-breaking clinical data presented at EuroPCR 2023 in Paris demonstrated Elixir Medical’s DynamX Bioadaptor restores vessel motion and function with better effectiveness at 12 months compared to a leading drug-eluting stent (DES).
May 17, 2023
EuroPCR Late-Breaking Clinical Trial Data Finds Effectiveness of Elixir Medical’s DynamX Bioadaptor for PCI Treatment
May 17, 2023 — Elixir Medical has reported that important data were presented at a late-breaking clinical session…
Read More
Heart Rhythm 2023, the society's 44th annual meeting, taking place May 19-21, in New Orleans
By Melinda Taschetta-Millane
May 17, 2023
HRS23 Announces Late-breaking Clinical Trials and Science Sessions
The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical…
Read More
Photo courtesy of James McCabe
May 16, 2023
Prowess, Persistence Yield First-anywhere Heart Procedure
March 16, 2023 — Cardiologists at the UW Medicine Heart Institute recently performed a first-in-the-world procedure,…
Read More
Fred Casciano, with wife Annette, is first patient to receive a new cath lab coronary artery bypass procedure at Henry Ford Health in Detroit.
May 16, 2023
Henry Ford Health Cardiologists look to the Past to Create New Heart Bypass Procedure
May 16, 2023 — Henry Ford Health Interventional cardiologists William O’Neill, M.D., and Khaldoon Alaswad, M.D., took a…
Read More
Philips Dynamic Coronary Roadmap
May 16, 2023
Philips’ Image-guided Navigation Increases Safety During Coronary Interventions
May 16, 2023 —  Royal Philips, a global leader in health technology, announced late-breaking data from the DCR4Contrast…
Read More
The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 billion by 2026. With a CAGR of 14.4% over the forecast period
By Kelly Patrick
May 15, 2023
Ambulatory Diagnostic Cardiology Market to Hit $3.3 Billion by 2026
The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3…
Read More
CRF Meeting on Structural Heart Disease Innovations will take place June 7-10
May 15, 2023
TVT 2023 Late-breaking Science Announced
May 15, 2023 — The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will…
Read More
Presentations include data on pulsed field ablation (PFA), disparities in atrial fibrillation (AFib) management, role of mapping and digital technologies in advancing cardiac arrhythmia treatment and real-world evidence informing treatment pathways
May 15, 2023
Biosense Webster Highlights New Research and Technology to Advance AFib Treatment at Heart Rhythm 2023
May 15, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
This research-use-only offering supports the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases
May 15, 2023
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360 BioPharma Research System
May 15, 2023 — Cardio Diagnostics Holdings, Inc, a precision cardiovascular medicine company, today announced the…
Read More
The Amvia family enables physiological pacing and workflow optimization to help physicians deliver exceptional patient-centric care with less effort.
May 12, 2023
Biotronic Receives CE Approval for the World’s First Pacemaker and CRT-P Family Approved for Left Bundle Branch Pacing
May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now